481PPhase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial. (23rd October 2018) - Osawa, H; Shinozaki, E; Nakamura, M; Ohhara, Y; Shindo, Y; Shiozawa, M; Uetake, H; Matsumoto, H; Ureshino, N; Satake, H; Kobayashi, T; Suto, T; et al.